Jeffrey Scott

Jeffrey Scott is an experienced legal and compliance professional currently serving as the Lead Compliance Counsel for Digital, Reporting, and Analytics at Pfizer.1 Here are some key details about his role and background:

Current Position

Jeffrey has been working at Pfizer since November 2010, holding his current position for over 13 years.1 In this role, he:

• Leads a multi-disciplinary team focusing on digital risk, innovation, and analytics
• Provides support to Pfizer's Digital organization's compliance program
• Manages a center of excellence model for digital risk issues
• Advises on global digital risk matters, particularly in the commercial space

Key Responsibilities

Digital Risk Management::

• Develops policies for emerging technologies, including Artificial Intelligence
• Advises on the use of third-party communication applications like WeChat and WhatsApp

Innovation::

• Leads a multi-year, multi-million dollar project to overhaul Compliance processes and systems

Analytics::

• Manages the Compliance Analytics Center of Excellence, providing analytics, visualization, and data science support across the Compliance Division

Additional Roles

Jeffrey also serves as co-lead for the Data and AI Ethics work stream for IFPMA's Ethics and Business Integrity Committee.1

Previous Experience

Before his current role, Jeffrey:

• Held a business-facing compliance position at Pfizer, supporting the Internal Medicine business and Global Commercial Operations
• Worked in Pfizer's Investigations group within the Compliance Division
• Was an Associate in Health Effects Litigation at Pepper Hamilton LLP
• Served as an Associate in Mass Torts and Insurance Litigation at Skadden Arps Slate Meagher & Flom

Education

• JD from the University of Pennsylvania Carey Law School (graduated cum laude)
• BA in History from Cornell University

Jeffrey Scott's extensive experience in compliance, digital risk management, and legal affairs has positioned him as a key figure in Pfizer's efforts to navigate the complex landscape of digital innovation and compliance in the pharmaceutical industry.1